Stock comparison
Medline Inc. is 1.7x more valuable than DEXCOM INC by market capitalization ($49.12 B vs $28.18 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MDLN is larger
Medline Inc. is 1.7x more valuable than DEXCOM INC by market capitalization ($49.12 B vs $28.18 B).
Market value leader
MDLN
Medline Inc. is 1.7x more valuable than DEXCOM INC by market capitalization ($49.12 B vs $28.18 B).
Revenue leader
MDLN
MDLN: $28.43B vs DXCM: $4.66B.
Profit leader
MDLN
MDLN: $1.16T vs DXCM: $836.30M.
Margin leader
MDLN
MDLN: 4069.4% vs DXCM: 17.9% net margin.
| Metric | MDLN | DXCM |
|---|---|---|
| Market cap | $49.12 B | $28.18 B |
| US-listed rank | #328 | #493 |
| Revenue (latest FY) | $28.43B | $4.66B |
| Net income (latest FY) | $1.16T | $836.30M |
| Net margin | 4069.4% | 17.9% |
| P/E (trailing FY) | 0.0x | 33.7x |
| SEC filings | 103 | 2,566 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medline Inc. is 1.7x more valuable than DEXCOM INC by market capitalization ($49.12 B vs $28.18 B).
In their latest fiscal years, Medline Inc. reported $28.43B in revenue while DEXCOM INC reported $4.66B.
Full pages: Medline Inc. and DEXCOM INC, or browse the full rankings.